Search results
Found 30795 matches for
Scientists in the Kennedy Institute, NDORMS show anti-TNF inhibits the cells responsible for Dupuytren’s disease.
Available studentship projects
Applications for this project are now closed.
UCB-Translational Pharmacology Scholarship
Applications for this project are now closed.
Themes
OCTRU runs trials across multiple areas of medicine. Within OCTRU there are five core therapeutic areas of expertise, although trials are also undertaken outside of these areas and groups.
Meet the team
-
Jagdeep Nanchahal
Professor of Hand, Plastic and Reconstructive Surgery
-
Sir Marc Feldmann FRS
Emeritus Professor
-
Fiona Powrie FRS
Professor of Musculoskeletal Sciences and Director of the Kennedy Institute
PROFESSOR Jagdeep Nanchahal talks about the Trial
Read the paper
The findings are published on line in the journal EBioMedicine, published by The Lancet.
FIND OUT ABOUT THE TRIAL
Funded by
Funding for the drug was provided by 180 Therapeutics.
Find out more about
Similar stories
New £50m MRC Centre to study how environmental exposures cause chronic inflammatory diseases
16 July 2025
A new Medical Research Council Centre of Research Excellence (MRC CoRE) will investigate how the environment interacts with our immune system to trigger chronic inflammatory diseases, such as asthma, chronic obstructive pulmonary disorder (COPD) and inflammatory bowel disease (IBD).